Loading...

VKTX VIKING THERAPEUTICS INC Expansion Plans 8-K Filing

VKNG

VKTX

VIKING THERAPEUTICS INC

(VKTX)

2025 8-K

Show Summary

Show Summary

Financial Statements

Supply Agreement

Clinical Trial Results

Q3 Financial Results

Earnings Reports

Results Announcement

Annual Meeting Approval

Earnings Reports

Clinical Trial Results

Underwriting Agreement for ...

Earnings Reports

Earnings Reports

Earnings Reports

Annual Meeting of Stockholders

Bylaw Amendment

Earnings Reports

Underwriting Agreement for ...

Clinical Study Initiation

Clinical Trial Results

Earnings Report

External Links:

On March 10, 2025, Viking Therapeutics entered into a Strategic Manufacturing and Supply Agreement with CordenPharma for the production of VK2735, involving prepayments totaling $90 million from 2025-2028. The agreement includes terms for manufacturing capacity and delivery for clinical trials and commercial use, with an initial term of eight years.

AI Assistant

VIKING THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.